Pancreatic Cancer Research

ResearcherRoswell Park Comprehensive Cancer CenterActive in the last 2 years

Aaron Scott Mansfield

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9483-6903; OpenAlex author ID A5071440718. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. Molecular Characterization and Therapeutic Opportunities in KRAS Wildtype Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers16101861↗
  2. Phase I dose escalation study of the PKCι inhibitor aurothiomalate for advanced non-small-cell lung cancer, ovarian cancer, and pancreatic cancer. Co-author DOI 10.1097/cad.0000000000000009↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Alex A. Adjei · 2 shared papers, 2013–2024 · strength 0.21
  2. Alexander Revzin · 1 shared paper, 2024 · strength 0.17
  3. Thorvardur Ragnar Halfdanarson · 1 shared paper, 2024 · strength 0.17
  4. Sani Haider Kizilbash · 1 shared paper, 2024 · strength 0.17
  5. Daniel H. Ahn · 1 shared paper, 2024 · strength 0.17
  6. Aakash P. Desai · 1 shared paper, 2024 · strength 0.17
  7. Daheui Choi · 1 shared paper, 2024 · strength 0.17
  8. Hani M. Babiker · 1 shared paper, 2024 · strength 0.17
  9. Steven R. Alberts · 1 shared paper, 2024 · strength 0.17
  10. Ryan Michael Carr · 1 shared paper, 2024 · strength 0.17
  11. Wen Wee Ma · 1 shared paper, 2024 · strength 0.17
  12. Tanios Bekaii‐Saab · 1 shared paper, 2024 · strength 0.17
  13. Robert R. McWilliams · 1 shared paper, 2024 · strength 0.17
  14. Amit Mahipal · 1 shared paper, 2024 · strength 0.17
  15. Aminah Jatoi · 1 shared paper, 2013 · strength 0.04
  16. Julian R. Molina · 1 shared paper, 2013 · strength 0.04
  17. Charles Erlichman · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.